Submit your papers Submit Now
International Peer-Reviewed Journal
For Enquiries: editor@iiardjournals.org
📄 Download Paper

Cox Proportional Hazards Analysis of Clinical and Demographic Determinants of Liver Cancer Survival

Isa Ahmed, Musa Dungus Musa, Alhaji Modu Isa, Falmata Alhaji Mai

Abstract

Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the leading causes of cancer-related mortality worldwide, with survival outcomes strongly influenced by demographic, clinical and tumor-related factors. This study applied the Cox Proportional Hazards (Cox PH) model to examine prognostic determinants of survival among liver cancer patients. A dataset consisting of 40 patients was analyzed, with survival time as the dependent variable and age, gender, blood level and tumor size as predictors. Results indicated that tumor size and gender had relatively strong associations with hazard, while age and blood level showed weaker, non- significant effects. The estimated hazard function demonstrated that older patients (80 years) faced higher risks of mortality compared to younger patients, with hazard peaks around 10–20 months and 60 months. Model diagnostics, including Cox-Snell residuals, confirmed that the proportional hazards assumption was satisfied, supporting the adequacy of the model for the dataset. The findings suggest that tumor size and gender may serve as key prognostic indicators for liver cancer survival, while also highlighting the heightened vulnerability of older patients.

Keywords

Liver Cancer Survival Analysis Cox Proportional Hazards Tumor Size

References

Gramling, R., Nash, J., Siren, K., & Eaton, J. (2016). Tumor size and survival in hepatocellular carcinoma: A population-based study. Journal of Gastrointestinal Oncology, 7(3), 456– 462.| Kim, J. H., Choi, E., & Lim, H. (2025). Conditional survival modeling in hepatocellular carcinoma: A dynamic Cox-based nomogram. Cancer Medicine, 14(2), 234–245. Kleinbaum, D. G., & Klein, M. (2012). Survival analysis: A self-learning text (3rd ed.). Springer. Lee, H. W., Cho, Y., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., … Ahn, S. H. (2021). Survival outcomes of hepatocellular carcinoma patients: A nationwide cohort study in Korea. Liver International, 41(3), 522–532. Lv, G., Wang, J., Guo, Y., & Liu, Y. (2025). Development of an individualized nomogram to predict prognosis in hepatocellular carcinoma patients after radical resection: A Cox regression analysis. European Journal of Medical Research, 30(1), 291. Park, J. H., Lee, S. Y., & Kim, Y. J. (2024). Treatment modality and survival disparities in hepatocellular carcinoma: A Cox-adjusted analysis. Journal of Hepatology Research, 12(4), 345–356. Patel, R., Singh, A., & Mehta, K. (2024). Long-term survival risk scoring for liver transplant candidates using Cox regression. Transplantation Journal, 108(5), 789–797. Sun, Y., Zhao, H., & Liu, Q. (2024). LASSO-Cox modeling for recurrence-free survival prediction in early-stage hepatocellular carcinoma. Statistical Methods in Medical Research, 33(1), 78–92. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. Tovoli, F., Dadduzio, V., De Lorenzo, S., Garuti, F., Masi, G., Piscaglia, F., Rimassa, L. (2023). Temporal trends in survival of advanced hepatocellular carcinoma patients: A multicenter Cox regression analysis, 2009–2022. Cancers, 15(23), 5841. Vento, S., & Cainelli, F. (2023). Liver cancer in sub-Saharan Africa: Challenges and perspectives. World Journal of Hepatology, 15(1), 1–10. Villanueva, A. (2019). Hepatocellular carcinoma. New England Journal of Medicine, 380(15), 1450–1462. Wang, X., Zhang, Y., & Chen, L. (2025). Comparative survival prediction in patients with bone metastases: Cox regression versus conventional staging. Journal of Clinical Oncology, 43(2), 112–120. Zhang, L., Huang, T., & Wu, D. (2025). Comparing Cox regression and random survival forests for liver cancer prognosis. Computational and Mathematical Methods in Medicine, 2025.